Hui Zhang1,
Lei Fu2 ,
Jingwen Jiang1,
Fangfang Fu1,
Aiying Chen1,
Hui Gong3,
Fengting Zhu1
For correspondence:- Lei Fu Email: 326655171@qq.com
Accepted: 27 March 2024 Published: 30 April 2024
Citation: Zhang H, Fu L, Jiang J, Fu F, Chen A, Gong H, et al. Efficacy and safety of the combination of paclitaxel, cisplatin and bevacizumab for the treatment of non-small cell lung cancer. Trop J Pharm Res 2024; 23(4):769-775 doi: 10.4314/tjpr.v23i4.13
© 2024 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates